Sub Heading

Clinical Trials Details

CORRECT-MRD II: Second colorectal cancer clinical validation study to predict recurrence using a circulating tumor DNA assay to detect minimal residual disease

IRB Protocol Number
16-002 / NSABP C-14

Clinical Trial Categories

  • Colorectal Cancer
Contact
Clinical Trials at 910-715-2200
How to Participate

Eligibility:  Men and women age 18 and older, with stage II or III colorectal cancer, within 3 months of complete surgical resection of primary tumor.

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.